Symbol: |
NHS
|
Description: |
Nance-Horan syndrome (congenital cataracts and dental anomalies) [Source:HGNC Symbol;Acc:7820]
|
Location: |
ChrX:17393543-17754114[+]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:276
Gene |
Compound |
Gen_sig |
Exp_pattern |
NHS |
Cyclopentanone, 2-[(4-morpholinyl)methyl]-5-nonylidene, hydrochloride |
0.024 |
Up |
NHS |
Cyclopentanone, 2-[(dimethylamino)methyl]-5-[(4-methoxy- phenyl)methylene]-, hydrochloride |
0.007 |
Up |
NHS |
Cyclopentanone, 2-[(dimethylamino)methyl]-5-[(3-methoxy- phenyl)methylene]-, hydrochloride |
0.005 |
Up |
NHS |
Cyclopentanone, 2-[(dimethylamino)methyl]-5-[(3,4- dimethoxyphenyl)methylene]-, hydrochloride |
0.007 |
Up |
NHS |
Chlorodestruxin |
0.033 |
Up |
NHS |
Pyrimidine, 2-[1,5-bis(4-chlorophenyl)-1H-1,2,3-triazol-4-yl]- 1,4,5,6-tetrahydro- |
0.015 |
Up |
NHS |
NSC 645364 |
0.003 |
Up |
NHS |
2-Propen-1-one, 1-(4-chlorophenyl)-3-[4-[2-oxo- 2-(4-phenyl-1-piperazinyl)ethoxy]phenyl]-, (E)- |
0.02 |
Down |
NHS |
NSC 648624 |
0.022 |
Down |
NHS |
4-Methylthio-N-(3,4,5-trimethoxybenzyl)aniline |
0.012 |
Up |
NHS |
NSC 650821 |
0.007 |
Down |
NHS |
NSC 651838 |
0.008 |
Up |
NHS |
NSC 655978 |
0.028 |
Up |
NHS |
NSC 657002 |
0.034 |
Up |
NHS |
NSC 657353 |
0.045 |
Up |
Expression pattern: Sensitivity / Resistance
Total:19 Current:5
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:20
Total:2 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:null
Gene |
Gen_transcript |
miRNA |
miR_location |
Total:0 Current:1
[First] [Prev] [Next] [Last]
|